National Metabolic MSL Director

Travere Therapeutics; United States; A distancia; USD 189.000 - 246.000; Jornada completa

Descripción de la vacante

Travere Therapeutics in the USA is seeking a Director, Medical Science Liaisons for National Metabolic to guide the US Field Medical team and drive strategic plans across clinical development and medical affairs.

The role demands leadership, robust scientific acumen, and strong cross-functional engagement with commercial and regulatory partners, with travel up to 50% as needed to engage investigators and key healthcare professionals.

Formación

• PharmD or PhD in a related life sciences discipline, MD, or an advanced clinical degree qualifying the individual as an advanced practice provider.
• 6+ years of field medical experience with leadership in Metabolic or related therapeutic areas.
• Extensive understanding of clinical, commercial, and regulatory standards in pharma.

Responsabilidades

• Interpret and translate national strategies into regional plans for the US Field Medical team.
• Proactively develops and ensures execution of field medical plans and initiatives.
• Contribute to vision, strategy, and goals for the US Field Medical team aligned with corporate strategies.
• Align opinion leader relationships with company needs on an ongoing basis.
• Oversee dissemination of scientific information within regulatory guidelines and standards.

Conocimientos

Leadership

Strategic thinking

Cross-functional collaboration

Regulatory knowledge

Communication skills

Educación

PharmD or PhD in life sciences

MD or advanced clinical degree

Herramientas

Microsoft Word

Excel

PowerPoint

Outlook

Descripción del empleo

Travere Therapeutics in the USA is seeking a Director, Medical Science Liaisons for National Metabolic to guide the US Field Medical team and drive strategic plans across clinical development and medical affairs.

The role demands leadership, robust scientific acumen, and strong cross-functional engagement with commercial and regulatory partners, with travel up to 50% as needed to engage investigators and key healthcare professionals.